Bluebird bio Inc (NASDAQ:BLUE) has a beta value of 0.83 and has seen 5.14 million shares traded in the last trading session. The company, currently valued at $177.86M, closed the last trade at $0.92 per share which meant it gained $0.01 on the day or 1.13% during that session. The BLUE stock price is -501.09% off its 52-week high price of $5.53 and 4.35% above the 52-week low of $0.88. The 3-month trading volume is 8.36 million shares.

Bluebird bio Inc (NASDAQ:BLUE) trade information

Sporting 1.13% in the green in last session, the stock has traded in the red over the last five days, when the BLUE stock price touched $0.92 or saw a rise of 12.38%. Year-to-date, Bluebird bio Inc shares have moved -33.13%, while the 5-day performance has seen it change -9.53%. Over the past 30 days, the shares of Bluebird bio Inc (NASDAQ:BLUE) have changed -32.40%.

Bluebird bio Inc (BLUE) estimates and forecasts

The company’s shares have lost -68.29% over the past 6 months, compared to 12.90% for the industry. Revenue growth from the last financial year stood is estimated to be 881.40%.

11 analysts offering their estimates for the company have set an average revenue estimate of $10.16 million for the current quarter. 9 have an estimated revenue figure of $19.55 million for the next quarter concluding in Mar 2024. Year-ago sales stood $62k and $2.38 million respectively for this quarter and the next, and analysts expect sales will grow by 16,287.10% for the current quarter and 721.10% for the next.

Earnings growth for 2024 is a modest 10.88% while over the next 5 years, the company’s earnings are expected to increase by 45.80%.

BLUE Dividends

Bluebird bio Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.